Womb (uterine or endometrial) cancer
Open
Phase 3
This trial is looking at radiotherapy and hormone therapy after surgery for womb cancer. It is comparing this to with chemotherapy and radiotherapy after surgery.
It is for women:
whose womb cancer hasn’t spread to distant parts of the body, and
who don’t have any specific gene changes () in their womb cancer cells. This is called no specific molecular profile womb cancer or NSMP for short.
Womb cancer is also called endometrial or uterine cancer.
NSMP-ORANGE is part of a larger study called the RAINBO study. The RAINBO study is made up of 4 different trials. It is looking at treatment options for different types of gene changes in womb cancer cells.
Recruitment start: 19 December 2025
Recruitment end: 31 December 2030
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Emma Davidson
Dr Melanie Powell
Cancer Research UK & UCL Cancer Trials Centre
University College London (UCL)
NIHR Health Technology Assessment (HTA) programme
Last reviewed: 26 May 2026
CRUK internal database number: 19880